|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2007-10-2
|
|
pubmed:abstractText |
A phase I/II study was first conducted for the treatment of stage I non-small cell lung cancer (NSCLC) from 1994 to 1999 to determine the optimal dose. On the basis on the results, a phase II study using a regimen of four fractions during 1 week was performed. The purpose of the present study was to determine the local control and 5-year survival rates.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
pubmed-author:BabaMasayukiM,
pubmed-author:EzawaHidefumiH,
pubmed-author:FujisawaTakehikoT,
pubmed-author:HirasawaNaokiN,
pubmed-author:KadonoKennoshukeK,
pubmed-author:KageiKennjiK,
pubmed-author:KandatsuSusumuS,
pubmed-author:KotoMasashiM,
pubmed-author:MiyamotoTadaakiT,
pubmed-author:MizoeJun-etsuJE,
pubmed-author:NakajimaMioM,
pubmed-author:SuganeToshioT,
pubmed-author:SugawaraToshiyukiT,
pubmed-author:TsujiiHirohikoH,
pubmed-author:Working Group for Lung Cancer,
pubmed-author:YamamotoNaoyoshiN,
pubmed-author:YashiroTomoyasuT,
pubmed-author:YoshikawaKyosanK
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
916-26
|
|
pubmed:dateRevised |
2008-5-6
|
|
pubmed:meshHeading |
pubmed-meshheading:17909354-Adenocarcinoma,
pubmed-meshheading:17909354-Aged,
pubmed-meshheading:17909354-Aged, 80 and over,
pubmed-meshheading:17909354-Carbon Radioisotopes,
pubmed-meshheading:17909354-Carcinoma, Adenosquamous,
pubmed-meshheading:17909354-Carcinoma, Large Cell,
pubmed-meshheading:17909354-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17909354-Carcinoma, Squamous Cell,
pubmed-meshheading:17909354-Dose Fractionation,
pubmed-meshheading:17909354-Female,
pubmed-meshheading:17909354-Humans,
pubmed-meshheading:17909354-Lung Neoplasms,
pubmed-meshheading:17909354-Male,
pubmed-meshheading:17909354-Middle Aged,
pubmed-meshheading:17909354-Neoplasm Recurrence, Local,
pubmed-meshheading:17909354-Neoplasm Staging,
pubmed-meshheading:17909354-Radiotherapy Dosage,
pubmed-meshheading:17909354-Survival Rate,
pubmed-meshheading:17909354-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week.
|
|
pubmed:affiliation |
Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan. t_miyamt@nirs.go.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
